The Commission has assessed the data provided by the applicant for magnesium L-threonate and determined it meets the requirements of Regulation (EU) 2015/2283. As a result, studies on its bioavailability and safety will be protected for five years. During this period, only the applicant is authorized to market magnesium L-threonate in the EU. However, other applicants can apply for authorization to sell the same product if they base their application on independently obtained data supporting its safety and compliance
News Region:
European Union
News Market:
European Union